GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » YoY EBITDA Growth

BCAX (Bicara Therapeutics) YoY EBITDA Growth : -74.64% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Bicara Therapeutics's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -74.64%.

Bicara Therapeutics's EBITDA per Share for the three months ended in Dec. 2024 was $-0.49.

Bicara Therapeutics YoY EBITDA Growth Historical Data

The historical data trend for Bicara Therapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics YoY EBITDA Growth Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
YoY EBITDA Growth
- 51.99 -317.65

Bicara Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial - - - - -74.64

Bicara Therapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Bicara Therapeutics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-4.899--1.173)/ | -1.173 |
=-317.65 %

Bicara Therapeutics's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(-0.489--0.28)/ | -0.28 |
=-74.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bicara Therapeutics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Bicara Therapeutics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Bicara Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » YoY EBITDA Growth
Comparable Companies
DAWN CMRX AVXL RCKT OCS QURE ABCL XNCR VIR LENZ VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Website
https://www.bicara.com
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.